Also trades as: ENSCW (OTC) · $vol 0M
ENSC NASDAQ
Ensysce Biosciences, Inc.
1W: -9.8%
1M: +12.2%
3M: +78.0%
YTD: -52.1%
1Y: -79.8%
3Y: -97.6%
5Y: -100.0%
$0.45
-0.00 (-0.02%)
Weekly Expected Move ±13.5%
$0
$0
$0
$1
$1
Credit Risk of going bust: higher than 81% of companies Debt: 2.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down 99%), Ensysce Biosciences, Inc. would be worth roughly what it owes.
Total debt $197K against a stock market value of $8.8M.
Distance to default 2.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $197K (short-term plus half of long-term), stock volatility 126.2%; Altman Z'' -192.37. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $197K against a stock market value of $8.8M.
Distance to default 2.50 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $197K (short-term plus half of long-term), stock volatility 126.2%; Altman Z'' -192.37. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships0
As Filer
counterparties named
2
As Counterparty
mentioned by others
2021-06-11
Earliest Filing
2025-02-04
Latest Filing
Mentioned As Counterparty
2 mentionsOther companies that named ENSC in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| ENSCW Ensysce Biosciences, Inc. | partner | Client obtaining pharmaceutical development and commercial manufacturing services | 2025-02-04 | View |
| ENSCW Leisure Acquisition Corp. | acquirer | Target company for the proposed business combination with Leisure Acquisition Corp. | 2021-06-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-16 | Exhibits | View | |
| 2026-09-29 | Bylaws Amendment; Exhibits | View | |
| 2026-08-25 | Other Events | View | |
| 2026-08-24 | Other Events | View | |
| 2026-08-13 | Earnings Release; Exhibits | View | |
| 2026-08-06 | Material Agreement; Acquisition/Disposition; Unregistered Equity Sales; Officer/Director Change; Byl | Agreement Acquisition | View |
| 2026-08-06 | Exhibits | View | |
| 2026-07-15 | Officer/Director Change; Exhibits | View | |
| 2026-05-22 | Delisting Notice | View | |
| 2026-05-15 | Earnings Release; Exhibits | View | |
| 2026-04-08 | Material Agreement; Unregistered Equity Sales; Other Events; Exhibits | Agreement | View |
| 2026-04-03 | Officer/Director Change; Exhibits | View | |
| 2026-03-30 | Officer/Director Change; Exhibits | View | |
| 2026-03-30 | Earnings Release; Exhibits | View | |
| 2026-03-23 | Bylaws Amendment; Exhibits | View | |
| 2026-02-27 | Notice of Delisting or Transfer | View | |
| 2026-01-08 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-11-17 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Art | Agreement | View |
| 2025-11-14 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-13 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR